HIRSCHMAN ORIN 13D and 13G filings for Adamas Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-10-20 3:42 pm Sale |
2021-10-11 | 13G | Adamas Pharmaceuticals, Inc. ADMS |
HIRSCHMAN ORIN | 0 0.000% |
-1,611,313 (Position Closed) |
Filing |
| 2021-02-22 07:18 am Purchase |
2021-02-16 | 13G | Adamas Pharmaceuticals, Inc. ADMS |
HIRSCHMAN ORIN | 1,611,313 11.000% |
1,611,313 (New Position) |
Filing |